骨髓增生异常综合征

  • 网络mds;Myelodysplastic Syndromes;MDS-RA;RAEB
骨髓增生异常综合征骨髓增生异常综合征
  1. 结果联合治疗苯中毒中,再障2例均治愈,1例骨髓增生异常综合征(MDS)明显进步,1例急性造血停滞治愈。

    Results 2 cases of aplastic anemia were cured and 1 case MDS was improved and 1 cured of stasis to produce blood .

  2. 沙利度胺联合环孢素A治疗骨髓增生异常综合征的临床研究

    Clinical research of thalidomide combined wit CsA in treatment of MDS

  3. DNA末端原位标记结合免疫酶标技术研究骨髓增生异常综合征原位细胞凋亡

    Study on apoptosis in myelodysplastic syndromes by DNA in situ end labelling combined with APAAP

  4. 目的提高与骨髓增生异常综合征(MDS)相关的Sweet综合征的(SS)认识。

    Objective To introduce Sweet 's syndrome ( SS ) associated with myelodysplastic syndrome ( MDS ) .

  5. 骨髓增生异常综合征FAB和WHO分型的临床评价

    Clinical assessment of FAB and WHO classification of myelodysplastic syndromes

  6. 36例骨髓增生异常综合征(MDS)患者有免疫功能异常。

    He immunological function abnormalities were found in 36 untreated patients with MDS .

  7. FAB与WHO对骨髓增生异常综合征的分型比较与分析

    Comparison and analyse FAB classification of myelodysplastic syndrome with WHO classification of myelodysplastic syndrome

  8. 骨髓增生异常综合征和急非淋白血病患者Ki-ras癌基因12位密码子点突变

    A point mutation at codon 12 of the Ki - ras oncogene in myelodysplastic syndrome

  9. 重组人G-CSF、EPO对白血病及骨髓增生异常综合征细胞的作用

    Effect of human recombinant g-csf , EPO on marrow cells in AML and MDS

  10. 目的:提高骨髓增生异常综合征(MDS)的实验室诊断水平及规范性。

    Objective To advance laboratory diagnose level and criterion character of myelodysplastic syndrome ( MDS ) .

  11. 骨髓增生异常综合征(MDS)的诊断进展

    Progress of Diagnosis in Myelodysplastic Syndrome

  12. 再生障碍性贫血和骨髓增生异常综合征患者骨髓CD(34)~+细胞及其表面的粒细胞&巨噬细胞集落刺激因子受体测定

    The Determination of CD34 Positive Cells and Granulocyte-Macrophage Colony-Stimulating Factor Receptors on CD34 Positive Cells in Bone Marrow of the Patients with Aplastic Anemia and Myelodysplastic Syndrome

  13. 目的探讨小儿骨髓增生异常综合征(MDS)的临床特点。

    AbstractObjectiveTo study the clinical characteristics and prognosis factors of myelodysplastic syndrome ( MDS ) in children .

  14. 目的探索小儿骨髓增生异常综合征(MDS)演变和转化规律。

    Objective To investigate the law of evolvement and transformation of myeloproliferative disorders syndrome ( MDS ) .

  15. 本文测定了11例骨髓增生异常综合征(MDS)患者的红细胞免疫功能。

    We observed the changes of red cell immune function in 11 patients with myelodysplastic syndrome ( MDS ) .

  16. 异常基因启动子甲基化导致骨髓增生异常综合征(MDS)患者造血祖细胞基因表达的失调。

    Abnormal gene promoter methylation contributes to deregulate gene expression of hematopoietic progenitors in myelodysplastic syndromes ( MDS ) .

  17. 先前对骨髓增生异常综合征(MDS)的表观遗传学研究主要集中于DNA甲基化所致的肿瘤抑制基因的失活。

    Previous research on the epigenetics of myelodysplastic syndromes ( MDS ) mainly focused on the inactivation of tumor suppressor genes as a result of DNA methylation .

  18. 目的:研究46例骨髓增生异常综合征(MDS)病程中ABO血型检定及抗体的变化。

    Objective : To investigate ABO blood group typing and antibody changes of46 patients with myelodysplastic syndrome ( MDS ) .

  19. 目的联合应用四种克隆性分析法对骨髓增生异常综合征(MDS)的早期诊断进行研究。

    Objective To evaluate the four techniques for clonal analysis in the early diagnosis of myelodysplastic syndromes ( MDS ) .

  20. 目的:评价免疫表型测定在骨髓增生异常综合征(MDS)诊断及分型中的价值。

    Objective : To evaluate the values of immunophenotyping in the diagnosis and classification of myelodysplastic syndromes ( MDS ) .

  21. 对28例骨髓增生异常综合征(MDS)患者骨髓活检组织的超微病理及细胞化学研究。

    Twenty eight bone-marrow biopsies from the patients with myelodysplastic syndromes ( MDS ) were studied with micropathology and cytochemistry .

  22. 目的探讨间期荧光原位杂交(FISH)技术在检测骨髓增生异常综合征(MDS)8号染色体三体(8三体)中的价值。

    Objective To explore the value of interphase fluorescence in situ hybridization ( FISH ) in the detection of trisomy 8 in myelodysplastic syndromes ( MDS ) .

  23. 【目的】研究伴染色体结构异常的骨髓增生异常综合征(MDS)患者的临床和实验室特点。

    【 Objective 】 To study the clinical and laboratory features of myelodysplastic syndromes ( MDS ) patients with chromosomal structural changes .

  24. 目的:调查白血病和骨髓增生异常综合征(MDS)患者红细胞酶和同工酶谱改变的患病率,并研究其临床意义。

    Objective : To define the prevalence of acquired red cell enzymopathy in leukemia and MDS patients and explore its clinical significance .

  25. 目的评价组合探针荧光原位杂交(fluorescenceinsitehybridization,FISH)在检测骨髓增生异常综合征(Myelodysplasticsyndrome,MDS)常见染色体异常中的价值。

    Objective To evaluate the value of a panel fluorescence in situ hybridization ( FISH ) in the detection of common chromosome abnormalities in myelodysplastic syndrome ( MDS ) .

  26. 前言:目的:通过对130例骨髓增生异常综合征(MDS)患者的涂片和切片联合检测来观察两者的临床价值。

    Objective : To explore the clinical significance of bone marrow smear and biopsy section by applying the two tests to130 MDS patients .

  27. 本文主要从原癌基因的异常表达、肿瘤抑制基因表达的缺失和DNA修复机制的异常等方面概括地论述了骨髓增生异常综合征基因缺陷的研究进展。

    This review summarizes the most recent developments in the understanding of the gene defects associated with MDS which mainly include altered expression of oncogenes , the loss of expression of tumor suppressor genes and the repair of DNA .

  28. HHT诱导骨髓增生异常综合征细胞MUTZ-1凋亡过程中活性氧和线粒体膜电位的变化

    Changes in reactive oxygen species and mitochondrial membrane potential in homoharringtonine-induced apoptosis of MUTZ-1 cells

  29. 目的:探讨获得性α-地中海贫血伴发骨髓增生异常综合征(MDS)的临床特点、诊断标准及发病机制。

    Objective : To investigate diagnostic criteria , clinical feature and pathogenesis of acquired α - thalassemia associated with myelodysplastic syndrome ( ATMDS ) .

  30. 目的研究骨髓增生异常综合征(MDS)患者骨髓细胞凋亡改变,以探讨MDS疾病本质。

    Objective To investigate the change of apoptosis of bone marrow mononuclear cells ( BMMNC ) in patients with myelodysplastic syndrome ( MDS ) .